17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

NCT00089271 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Cancer Institute (NCI)